MY101175A - External medication - Google Patents

External medication

Info

Publication number
MY101175A
MY101175A MYPI87000395A MYPI19870395A MY101175A MY 101175 A MY101175 A MY 101175A MY PI87000395 A MYPI87000395 A MY PI87000395A MY PI19870395 A MYPI19870395 A MY PI19870395A MY 101175 A MY101175 A MY 101175A
Authority
MY
Malaysia
Prior art keywords
medications
effects
external
formula
external medications
Prior art date
Application number
MYPI87000395A
Other languages
English (en)
Inventor
Kamiya Tetsuro
Tsuchiya Shuichi
Hara Kenji
Original Assignee
Kao Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=16647927&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=MY101175(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Kao Corp filed Critical Kao Corp
Publication of MY101175A publication Critical patent/MY101175A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Dermatology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Saccharide Compounds (AREA)
MYPI87000395A 1985-09-27 1987-03-30 External medication MY101175A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP60213961A JPS6272611A (ja) 1985-09-27 1985-09-27 皮膚外用剤

Publications (1)

Publication Number Publication Date
MY101175A true MY101175A (en) 1991-07-31

Family

ID=16647927

Family Applications (1)

Application Number Title Priority Date Filing Date
MYPI87000395A MY101175A (en) 1985-09-27 1987-03-30 External medication

Country Status (6)

Country Link
US (1) US4879274A (enExample)
EP (1) EP0216303B1 (enExample)
JP (1) JPS6272611A (enExample)
DE (1) DE3678517D1 (enExample)
HK (1) HK41793A (enExample)
MY (1) MY101175A (enExample)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5116603A (en) * 1989-01-31 1992-05-26 Yissum Research Development Company Of The Hebrew University Of Jerusalem Oral antifungal preventative, and method of use
AU634358B2 (en) * 1990-03-02 1993-02-18 Shiseido Company Ltd. Oil-in-water emulsion composition containing nonsteroidal antiphlogistic analgesic
EP0592569A1 (en) * 1991-07-03 1994-04-20 Sano Corporation Composition and method for transdermal delivery of diclofenac
FR2679467B1 (fr) * 1991-07-26 1993-10-15 Oreal Dispersion solide d'au moins un alcool polyhydrique dans un milieu anhydre et procede de preparation.
CA2123780A1 (en) * 1991-12-11 1993-06-24 Ronald A. Pieringer Amphotericin b composition with enhanced antifungal activity
JPH08501529A (ja) * 1992-06-11 1996-02-20 セラテック・インコーポレイテッド 皮膚透過薬剤投与緩和のグリセリン使用
DE4240674C2 (de) * 1992-11-26 1999-06-24 Schuelke & Mayr Gmbh Desodorierende Wirkstoffe
DE4345186C2 (de) * 1993-12-27 1997-08-14 Galderma Sa Hydrocortison-21-acetat-17-propionat enthaltende W/O-Lotionen
US5990179A (en) * 1995-04-28 1999-11-23 Alza Corporation Composition and method of enhancing electrotransport agent delivery
US6117119A (en) * 1998-08-28 2000-09-12 Silipos, Inc. Gelatinous body protection article having a therapeutic additive
US6325788B1 (en) 1998-09-16 2001-12-04 Mckay Douglas William Treatment of wound or joint for relief of pain and promotion of healing
DE10025124B4 (de) * 2000-05-20 2015-07-16 Beiersdorf Ag Kombinationen von Glycerinmonoalkylethern und Aryl-substituierten Alkoholen
DE10028638A1 (de) * 2000-06-09 2001-12-20 Schuelke & Mayr Gmbh Lagerstabile Zusammensetzungen von Glycerinmonoalkylethern
US6383505B1 (en) 2000-11-09 2002-05-07 Steris Inc Fast-acting antimicrobial lotion with enhanced efficacy
US20030198616A1 (en) * 2002-04-23 2003-10-23 Combe Incorporated Moisturizing skin gel and method
US8968755B2 (en) 2010-10-23 2015-03-03 Joel Schlessinger Topical base and active agent-containing compositions, and methods for improving and treating skin
US8685381B2 (en) 2010-10-23 2014-04-01 Joel Schlessinger Topical base and active agent-containing compositions, and methods for improving and treating skin

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5639033A (en) * 1979-09-04 1981-04-14 Kao Corp Alpha-mono(methyl-branched alkyl glyceryl ether and skin cosmetic containing the same
JPS57123108A (en) * 1981-01-26 1982-07-31 Kao Corp Water-in-oil type emulsion

Also Published As

Publication number Publication date
DE3678517D1 (de) 1991-05-08
EP0216303A3 (en) 1987-10-28
JPH0244815B2 (enExample) 1990-10-05
EP0216303A2 (en) 1987-04-01
EP0216303B1 (en) 1991-04-03
HK41793A (en) 1993-05-07
JPS6272611A (ja) 1987-04-03
US4879274A (en) 1989-11-07

Similar Documents

Publication Publication Date Title
JPS6442476A (en) Benzothiazole derivative and antirheumatic agent containing said derivative as active ingredient
LV10270B (en) Novel pharmacological compounds
IL81002A (en) 3,4-diphenyl-pyrazoline-1-carboxamide derivatives,processes for the preparation thereof and insecticidal and acaricidal compositions containing the same
HU906284D0 (en) Process for the production of 24-homo-d-vitamin derivatives and medical preparations containing them as active agents
GR3003887T3 (enExample)
JPS6466159A (en) Vanadyl organic-inorganic compound and manufacture of drug composition containing same
AU4511485A (en) 2-substituted-1, 3-propylidenediphosphonate derivatives, the process for their preparation and pharmaceutical compositions containing them
SE8703032L (sv) Perkutan administrering av lekemedel
JPS57136567A (en) N-2-hydroxy-3-substituted piperidine compound
ES8708240A1 (es) Un procedimiento para la preparacion de nuevos compuestos poliprenilicos
NO903058L (no) Farmasoeytisk preparat med forbedret absorberbarhet.
ES8403463A1 (es) "un procedimiento para la preparacion de un compuesto de imidazol".
FI884838A0 (fi) Nytt s-timololderivat och foerfarande foer dess framstaellning.
KR910005860A (ko) 항간질환성 조성물
JPS5673046A (en) Decaprenylamine derivative
KR890005119A (ko) 마크롤리드 화합물
JPS6431717A (en) Antitumor agent
EP0348664A3 (en) Pharmaceutical compositions containing monoacetoacetins for treating tumours
SE8204872D0 (sv) Farmaceutiska preparat, innefattande humant insulin, human c-peptid och humant proinsulin
ES2010282A6 (es) Procedimiento para reparar 8 -acilaminoergolina.
ES8105273A1 (es) Procedimiento para la obtencion de derivados de guanidina
ES8702354A1 (es) Procedimiento para la obtencion de compuestos conteniendo grupos tiocianatometiltio
KR950702942A (ko) 암의 간전이 억제용 의약 조성물 및 간암 치료용 의약 조성물(pharmaceutical compositions for preventing liver metastasis of cancer and pharmaceutical composition for the treatment of liver cancer)
JPS5639074A (en) Pyrimidine derivative
JPS643144A (en) Novel cyclic compound and antilipemic agent containing said compound as active component